Vr Adviser, LLC Portfolio Holdings

Vr Adviser, LLC

$966 Million
Q3 2024

Vr Adviser, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $966 Million distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $111M, Viridian Therapeutics, Inc.\De with a value of $88.3M, Applied Therapeutics Inc. with a value of $83.5M, Dyne Therapeutics, Inc. with a value of $78.1M, and Kal Vista Pharmaceuticals, Inc. with a value of $72.4M.

Examining the 13F form we can see an increase of $53.9M in the current position value, from $912M to 966M.

Vr Adviser, LLC is based out at New York, NY

Below you can find more details about Vr Adviser, LLC portfolio as well as his latest detailed transactions.

Portfolio value $966 Million

Healthcare: $966 Million

Stock Holdings Table Companies Only

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
OCUL Ocular Therapeutix, Inc Healthcare	$650M	$111 Million 11.5% of portfolio	12,762,462	Q1 2024 Added 64.13%
VRDN Viridian Therapeutics, Inc.\De Healthcare	$776M	$88.3 Million 9.15% of portfolio	3,882,709	Q3 2024 Added 0.0%
APLT Applied Therapeutics Inc. Healthcare	$40.8M	$83.5 Million 8.65% of portfolio	9,825,000	Q3 2024 Added 2.96%
DYN Dyne Therapeutics, Inc. Healthcare	$1.23B	$78.1 Million 8.09% of portfolio	2,173,913	Q2 2023 New
KALV Kal Vista Pharmaceuticals, Inc. Healthcare	$210M	$72.4 Million 7.5% of portfolio	6,249,731	Q1 2024 Added 52.7%
PHVS Pharvaris N.V. Healthcare	$656M	$62.9 Million 6.51% of portfolio	3,395,606	Q4 2023 Added 117.18%
COGT Cogent Biosciences, Inc. Healthcare	$509M	$61.4 Million 6.36% of portfolio	5,684,167	Q2 2024 Added 10.82%
FDMT 4 D Molecular Therapeutics, Inc. Healthcare	$180M	$47.6 Million 4.93% of portfolio	4,400,000	Q1 2024 Added 28.5%
MRUS Merus N.V. Healthcare	$1.93B	$45.4 Million 4.7% of portfolio	907,963	Q3 2024 Reduced 28.12%
ORIC Oric Pharmaceuticals, Inc. Healthcare	$327M	$45 Million 4.67% of portfolio	4,394,527	Q1 2024 Added 80.97%
ERAS Erasca, Inc. Healthcare	$310M	$44.3 Million 4.58% of portfolio	16,216,216	Q2 2024 New
ATXS Astria Therapeutics, Inc. Healthcare	$139M	$38.1 Million 3.94% of portfolio	3,458,645	Q3 2024 Reduced 4.16%
TERN Terns Pharmaceuticals, Inc. Healthcare	$217M	$28.4 Million 2.95% of portfolio	3,410,058	Q1 2024 Reduced 24.17%
AQST Aquestive Therapeutics, Inc. Healthcare	$188M	$27.7 Million 2.87% of portfolio	5,555,555	Q1 2024 New
EWTX Edgewise Therapeutics, Inc. Healthcare	$1.82B	$26.7 Million 2.76% of portfolio	1,000,000	Q3 2024 Reduced 45.0%
CGEM Cullinan Oncology, Inc. Healthcare	$548M	$23.1 Million 2.39% of portfolio	1,379,965	Q2 2024 New
MRSN Mersana Therapeutics, Inc. Healthcare	$146M	$21.4 Million 2.22% of portfolio	11,328,000	Q3 2023 New
TSHA Taysha Gene Therapies, Inc. Healthcare	$89.9M	$18.1 Million 1.87% of portfolio	9,000,000	Q1 2024 Reduced 13.57%
TRVI Trevi Therapeutics, Inc. Healthcare	$249M	$11.4 Million 1.18% of portfolio	3,422,656	Q3 2024 Added 0.0%
ARVN Arvinas, Inc. Healthcare	$1.01B	$11.2 Million 1.16% of portfolio	454,450	Q3 2024 Reduced 27.61%
IPSC Century Therapeutics, Inc. Healthcare	$61.2M	$9.22 Million 0.95% of portfolio	5,389,259	Q2 2024 Added 58.27%
CABA Cabaletta Bio, Inc. Healthcare	$66.4M	$7.38 Million 0.76% of portfolio	1,563,952	Q1 2024 Reduced 39.0%
TNYA Tenaya Therapeutics, Inc. Healthcare	$62M	$3 Million 0.31% of portfolio	1,555,556	Q1 2024 New

Summary

Portfolio
No. of Stocks 38
Current Value $966 Million
Prior Value $912 Million
Filing
Period Q3 2024
Filing Date November 14, 2024
Form Type 13F-HR
Activity in Q3 2024
New Purchases 4 stocks
Additional Purchases 5 stocks
Sold out of 0 stocks
Reduced holdings in 6 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Account